Michael Chancellor's most recent trade in Lipella Pharmaceuticals Inc was a trade of 80,000 Stock Options done . Disclosure was reported to the exchange on March 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lipella Pharmaceuticals Inc | Michael Chancellor | Director, Chief Medical Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 80,000 | 80,000 | - | - | Stock Options | |
| Lipella Pharmaceuticals Inc | Michael Chancellor | Director, Chief Medical Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.69 per share. | 13 Mar 2024 | 144,906 | 877,637 | - | 0.7 | 100,000 | Common Stock |
| Lipella Pharmaceuticals Inc | Michael Chancellor | Director, Chief Medical Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 79,500 | 79,500 | - | - | Stock Options | |
| Lipella Pharmaceuticals Inc | Michael Chancellor | Director, Chief Medical Officer, Ten Percent Owner | Other type of transaction at price $ 5.75 per share. | 22 Dec 2022 | 22,950 | 732,730 | - | 5.8 | 131,963 | Common Stock |